产品
编 号：F438735
分子式：C22H22N6O7S2
分子量：546.58
分子式：C22H22N6O7S2
分子量：546.58
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
500mg
询价
询价
1g
询价
询价
5g
询价
询价
结构图
CAS No: 72558-82-8
产品详情
生物活性：
Ceftazidime (GR20263), an antibiotic, has a broad spectrum activity against Gram-positive and Gram-negative aerobic bacteria. Ceftazidime is also active against Enterobacteriaceae (including β-lactamase-positive strains) and is resistant to hydrolysis by most β-lactamases.
体内研究：
Ceftazidime (注射 2 小时，2 000 毫克，每 8 小时一次，持续 24 小时) 适度降低小鼠大腿感染模型中的细菌密度。Animal Model:Murine thigh infection model
Dosage:2000 mg
Administration:2 h infusion of injection, every 8 h for 24 h.
Result:Reduced bacterial density against the isogenic NDM (New Delhi metallo-β-lactamase) strain.
体外研究：
Ceftazidime (约 0-8 μg/mL，24 小时) 显示出针对 P. aeruginosa strains 的抗菌和抗生物膜活性。 Ceftazidime (0-40 μg/mL approximately，18 -20 h) 对 S. maltophilia 具有抑制活性。
Ceftazidime (GR20263), an antibiotic, has a broad spectrum activity against Gram-positive and Gram-negative aerobic bacteria. Ceftazidime is also active against Enterobacteriaceae (including β-lactamase-positive strains) and is resistant to hydrolysis by most β-lactamases.
体内研究：
Ceftazidime (注射 2 小时，2 000 毫克，每 8 小时一次，持续 24 小时) 适度降低小鼠大腿感染模型中的细菌密度。Animal Model:Murine thigh infection model
Dosage:2000 mg
Administration:2 h infusion of injection, every 8 h for 24 h.
Result:Reduced bacterial density against the isogenic NDM (New Delhi metallo-β-lactamase) strain.
体外研究：
Ceftazidime (约 0-8 μg/mL，24 小时) 显示出针对 P. aeruginosa strains 的抗菌和抗生物膜活性。 Ceftazidime (0-40 μg/mL approximately，18 -20 h) 对 S. maltophilia 具有抑制活性。
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备